Characterization of plasma-derived protoporphyrin-IX-positive extracellular vesicles following 5-ALA use in patients with malignant glioma

@article{pmid31628025,
    Author = "Jones, P. S. and Yekula, A. and Lansbury, E. and Small, J. L. and Ayinon, C. and Mordecai, S. and Hochberg, F. H. and Tigges, J. and Delcuze, B. and Charest, A. and Ghiran, I. and Balaj, L. and Carter, B. S.",
    Title = "{{C}haracterization of plasma-derived protoporphyrin-{I}{X}-positive extracellular vesicles following 5-{A}{L}{A} use in patients with malignant glioma}",
    Journal = "EBioMedicine",
    Year = "2019",
    Volume = "48",
    Pages = "23--35",
    Month = "Oct",
    Abstract = "Malignant gliomas are rapidly progressive brain tumors with high mortality. Fluorescence guided surgery (FGS) with 5-aminolevulinic acid (5-ALA) provides fluorescent delineation of malignant tissue, which helps achieve maximum safe resection. 5-ALA-based fluorescence is due to preferential accumulation of the fluorophore protoporphyrin-IX (PpIX) in malignant glioma tissue. Additionally, gliomas cells release extracellular vesicles (EVs) which carry biomarkers of disease. Herein, we performed animal and human studies to investigate whether 5-ALA dosed glioma cells, in vitro and in vivo, release PpIX positive EVs in circulation which can be captured and analyzed.\\ We used imaging flow cytometry (IFC) to characterize PpIX-positive EVs released from 5-ALA-dosed glioma cells, glioma-bearing xenograft models, as well as patients with malignant glioma undergoing FGS.\\ We first show that glioma cells dosed with 5-ALA release 247-fold higher PpIX positive EVs compared to mock dosed glioma cells. Second, we demonstrate that the plasma of glioma-bearing mice (n = 2) dosed with 5-ALA contain significantly higher levels of circulating PpIX-positive EVs than their pre-dosing background (p = 0.004). Lastly, we also show that the plasma of patients with avidly fluorescent tumors (n = 4) undergoing FGS contain circulating PpIX-positive EVs at levels significantly higher than their pre-dosing background (p = 0.00009) and this rise in signal correlates with enhancing tumor volumes (r 2 = 0.888).\\ Our findings highlight the potential of plasma-derived PpIX-positive EV-based diagnostics for malignant gliomas, offering a novel liquid biopsy platform for confirming and monitoring tumor status.",
    Note = "[PubMed Central:\href{https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838454}{PMC6838454}] [DOI:\href{https://dx.doi.org/10.1016/j.ebiom.2019.09.025}{10.1016/j.ebiom.2019.09.025}] [PubMed:\href{https://www.ncbi.nlm.nih.gov/pubmed/12493610}{12493610}]"
}